Walleye Trading LLC Clovis Oncology, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 08, 2022	SELL	$0.63 - $2.96 $504 - $2,368	-800 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $7,865 - $17,270	-5,500 Reduced 87.3%	800 $2,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $33,480 - $59,024	-12,400 Reduced 66.31%	6,300 $17,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $18,270 - $26,100	4,500 Added 31.69%	18,700 $83,000
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $42,670 - $59,925	8,500 Added 149.12%	14,200 $82,000
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $44,733 - $96,162	-9,300 Reduced 62.0%	5,700 $40,000
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $9,499 - $14,743	-2,300 Reduced 13.29%	15,000 $72,000
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $6,266 - $10,036	-1,300 Reduced 6.99%	17,300 $101,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $101,851 - $173,451	17,900 Added 2557.14%	18,600 $126,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $171,535 - $500,500	-45,500 Reduced 98.48%	700 $4,000
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $27,600 - $151,156	9,200 Added 24.86%	46,200 $482,000
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $203,181 - $793,595	-51,700 Reduced 58.29%	37,000 $145,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $1.12 Million - $2.25 Million	87,700 Added 8770.0%	88,700 $1.32 Million
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $17,660 - $30,280	1,000 New	1,000 $25,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $58,150 - $163,350	-5,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $766,557 - $1.29 Million	-26,100 Reduced 83.92%	5,000 $147,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $1.31 Million - $1.94 Million	31,100 New	31,100 $1.41 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account